Risk of hepatobiliary cancer after solid organ transplant in the United States

Clinical Gastroenterology and Hepatology

Volumn 12, Issue 9, 2014, Pages

  Koshiol, Jill ^a   Pawlish, Karen ^b   Goodman, Marc T ^c,d   McGlynn, Katherine A ^a   Engels, Eric A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NEW JERSEY DEPARTMENT OF HEALTH AND SENIOR SERVICES   (United States)

^c UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Epidemiology; HBV; HCV; Liver disease; Transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS;

ADOLESCENT; ADULT; AGED; ALCOHOL LIVER DISEASE; ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT CANCER; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CHILD; CHOLESTATIC LIVER DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; GALLBLADDER CANCER; GLOMERULOPATHY; GRAFT RECIPIENT; HEART TRANSPLANTATION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATOBILIARY SYSTEM CANCER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER TRANSPLANTATION; LUNG TRANSPLANTATION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; NEPHROSCLEROSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORGAN TRANSPLANTATION; PRESCHOOL CHILD; PRIMARY SCLEROSING CHOLANGITIS; RISK FACTOR; SCHOOL CHILD; STANDARDIZED INCIDENCE RATIO; STEROID THERAPY; UNDERWEIGHT; UNITED STATES; VATER PAPILLA CARCINOMA; VERY ELDERLY; BODY MASS; DISEASE ASSOCIATION; DRUG INDUCED CANCER; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; NEWBORN; POPULATION; PRIMARY BILIARY CIRRHOSIS; VATER PAPILLA TUMOR; BILIARY TRACT NEOPLASMS; INCIDENCE; LIVER NEOPLASMS; MIDDLE AGED; NEOPLASM; RISK ASSESSMENT; TRANSPLANTATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BILIARY TRACT NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS; RISK ASSESSMENT; TRANSPLANTS; UNITED STATES; YOUNG ADULT;

EID: 84906790518     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2013.12.018     Document Type: Article

References (24)

1. Ferlay J., Shin H.R., Bray F., et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127:2893-2917.
2. Altekruse S.F., McGlynn K.A., Reichman M.E. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. JClin Oncol 2009, 27:1485-1491.
3. McGlynn K.A., Tarone R.E., El-Serag H.B. Acomparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States. Cancer Epidemiol Biomarkers Prev 2006, 15:1198-1203.
4. Castro F.A., Koshiol J., Hsing A.W., et al. Biliary tract cancer incidence in the United States-demographic and temporal variations by anatomic site. Int J Cancer 2013, 133:1664-1671.
5. Peery A.F., Dellon E.S., Lund J., et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology 2012, 143:1179-1187.
6. Engels E.A., Pfeiffer R.M., Fraumeni J.F., et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA 2011, 306:1891-1901.
7. Hsing A.W., Zhang M., Rashid A., et al. Hepatitis B and C virus infection and the risk of biliary tract cancer: a population-based study in China. Int J Cancer 2008, 122:1849-1853.
8. Tyson G.L., El-Serag H.B. Risk factors for cholangiocarcinoma. Hepatology 2011, 54:173-184.
9. Adami J., Gabel H., Lindelof B., et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer 2003, 89:1221-1227.
10. Villeneuve P.J., Schaubel D.E., Fenton S.S., et al. Cancer incidence among Canadian kidney transplant recipients. Am J Transplant 2007, 7:941-948.
11. Gupta A., Bowlus C.L. Primary sclerosing cholangitis: etiopathogenesis and clinical management. Front Biosci (Elite Ed) 2012, 4:1683-1705.
12. Portincasa P., Vacca M., Moschetta A., et al. Primary sclerosing cholangitis: updates in diagnosis and therapy. World J Gastroenterol 2005, 11:7-16.
13. Fonck C., Chauveau D., Gagnadoux M.F., et al. Autosomal recessive polycystic kidney disease in adulthood. Nephrol Dial Transplant 2001, 16:1648-1652.
14. Sasaki M., Katayanagi K., Watanabe K., et al. Intrahepatic cholangiocarcinoma arising in autosomal dominant polycystic kidney disease. Virchows Arch 2002, 441:98-100.
15. Vauthey J.N., Maddern G.J., Blumgart L.H. Adult polycystic disease of the liver. Br J Surg 1991, 78:524-527.
16. Bangash H.K., Colegio O.R. Management of non-melanoma skin cancer in immunocompromised solid organ transplant recipients. Curr Treat Options Oncol 2012, 13:354-376.
17. Bugelski P.J., Volk A., Walker M.R., et al. Critical review of preclinical approaches to evaluate the potential of immunosuppressive drugs to influence human neoplasia. Int J Toxicol 2010, 29:435-466.
18. Hino-Arinaga T., Ide T., Kuromatsu R., et al. Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1. JGastroenterol 2012, 47:569-576.
19. Bjornsson E.S., Bergmann O.M., Bjornsson H.K., et al. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology 2013, 144:1419-1425.
20. Cruz R.J., Dew M.A., Myaskovsky L., et al. Objective radiologic assessment of body composition in patients with end-stage liver disease: going beyond the BMI. Transplantation 2013, 95:617-622.
21. Hoffmann C.J., Subramanian A.K., Cameron A.M., et al. Incidence and risk factors for hepatocellular carcinoma after solid organ transplantation. Transplantation 2008, 86:784-790.
22. Vajdic C.M., McDonald S.P., McCredie M.R., et al. Cancer incidence before and after kidney transplantation. JAMA 2006, 296:2823-2831.
23. Collett D., Mumford L., Banner N.R., et al. Comparison of the incidence of malignancy in recipients of different types of organ: a UK registry audit. Am J Transplant 2010, 10:1889-1896.
24. Busnach G., Piselli P., Arbustini E., et al. Immunosuppression and cancer: a comparison of risks in recipients of organ transplants and in HIV-positive individuals. Transplant Proc 2006, 38:3533-3535.